menu toggle

May 17, 2024

Now available TOFIDENCE™

TOFIDENCE™ (tocilizumab-bavi) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of:

Rheumatoid Arthritis (RA)
  • Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
    • Polyarticular Juvenile Idiopathic Arthritis (PJIA)
  • Patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis.
    • Systemic Juvenile Idiopathic Arthritis (SJIA)
  • Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

    •  

    Please see full prescribing information here.

    More Company News

    News

    Now available NEMLUVIO®

    August 2024

    News

    Now available VORANIGO®

    August 2024

    News

    Now available IMDELLTRA™

    May 2024